Targeting the endothelin receptor in prostate cancer bone metastasis: Back to the mouse?

Commentary to: Bone-specific growth inhibition of prostate cancer metastasis by Atrasentan Justin M. Drake, Joshua R. Danke and Michael Henry

Saved in:
Bibliographic Details
Published in:Cancer biology & therapy 2010-04, Vol.9 (8), p.615-617
Main Authors: Roh, Meejeon, Abdulkadir, Sarki A.
Format: Article
Language:English
Subjects:
Animals
Atrasentan
Binding
Biology
Bioscience
Bone Neoplasms - drug therapy
Bone Neoplasms - secondary
Calcium
Cancer
Cell
Cycle
Disease Models, Animal
Endothelin Receptor Antagonists
Humans
Landes
Male
Mice
Molecular Targeted Therapy - methods
Organogenesis
Prostatic Neoplasms - drug therapy
Prostatic Neoplasms - pathology
Proteins
Pyrrolidines - pharmacology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c517t-e3e5602d041ce4bf1ef9f80625996543cc2509aae3409a872538f8e694467d893
cites
container_end_page 617
container_issue 8
container_start_page 615
container_title Cancer biology & therapy
container_volume 9
creator Roh, Meejeon
Abdulkadir, Sarki A.
description Commentary to: Bone-specific growth inhibition of prostate cancer metastasis by Atrasentan Justin M. Drake, Joshua R. Danke and Michael Henry
doi_str_mv 10.4161/cbt.9.8.11309
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3024832</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>748965729</sourcerecordid><originalsourceid>FETCH-LOGICAL-c517t-e3e5602d041ce4bf1ef9f80625996543cc2509aae3409a872538f8e694467d893</originalsourceid><addsrcrecordid>eNqFUU1v1DAQtRCIlsKRK8qNU7a2Yzs2BxBd8SVVQkKLxM1ynMmuIbGD7aXqv6_TLSuQKvU0I_vNm3nvIfSS4BUjgpzbLq_USq4IabB6hE4J57yWvBWPl76RNcOsPUHPUvqJMW2pUE_RCcWE41bIU_RjY-IWsvPbKu-gAt-HUkfnqwgW5hxiVfo5hpRNhsoabyFWXfBQTZBNeU0uvakujP1V5XDLMYV9gnfP0ZPBjAle3NUz9P3jh836c3359dOX9fvL2nLS5hoa4ALTHjNigXUDgUENEgvKlRKcNdZSjpUx0LBSZEuLpEGCUIyJtpeqOUNvD7zzvpugt-BzNKOeo5tMvNbBOP3_j3c7vQ1_dIMpkw0tBK_vCGL4vYeU9eSShXE0HooS3TJZLmnpsqo-IG2xI0UYjlsI1ksYuoShlZb6NoyCf_XvaUf0X_cLgBwAZVcPqXMhWQfF4SN0ITQxOzvCkfT8gRmsvoXd-mKzHDL3Q5mQhwnnhxAncxXi2OtsrscQh1gCdUk39yu4ARvOvSo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>748965729</pqid></control><display><type>article</type><title>Targeting the endothelin receptor in prostate cancer bone metastasis: Back to the mouse?</title><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Roh, Meejeon ; Abdulkadir, Sarki A.</creator><creatorcontrib>Roh, Meejeon ; Abdulkadir, Sarki A.</creatorcontrib><description>Commentary to: Bone-specific growth inhibition of prostate cancer metastasis by Atrasentan Justin M. Drake, Joshua R. Danke and Michael Henry</description><identifier>ISSN: 1538-4047</identifier><identifier>EISSN: 1555-8576</identifier><identifier>DOI: 10.4161/cbt.9.8.11309</identifier><identifier>PMID: 20150768</identifier><language>eng</language><publisher>United States: Taylor &amp; Francis</publisher><subject>Animals ; Atrasentan ; Binding ; Biology ; Bioscience ; Bone Neoplasms - drug therapy ; Bone Neoplasms - secondary ; Calcium ; Cancer ; Cell ; Cycle ; Disease Models, Animal ; Endothelin Receptor Antagonists ; Humans ; Landes ; Male ; Mice ; Molecular Targeted Therapy - methods ; Organogenesis ; Prostatic Neoplasms - drug therapy ; Prostatic Neoplasms - pathology ; Proteins ; Pyrrolidines - pharmacology</subject><ispartof>Cancer biology &amp; therapy, 2010-04, Vol.9 (8), p.615-617</ispartof><rights>Copyright © 2010 Landes Bioscience 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c517t-e3e5602d041ce4bf1ef9f80625996543cc2509aae3409a872538f8e694467d893</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024832/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024832/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20150768$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roh, Meejeon</creatorcontrib><creatorcontrib>Abdulkadir, Sarki A.</creatorcontrib><title>Targeting the endothelin receptor in prostate cancer bone metastasis: Back to the mouse?</title><title>Cancer biology &amp; therapy</title><addtitle>Cancer Biol Ther</addtitle><description>Commentary to: Bone-specific growth inhibition of prostate cancer metastasis by Atrasentan Justin M. Drake, Joshua R. Danke and Michael Henry</description><subject>Animals</subject><subject>Atrasentan</subject><subject>Binding</subject><subject>Biology</subject><subject>Bioscience</subject><subject>Bone Neoplasms - drug therapy</subject><subject>Bone Neoplasms - secondary</subject><subject>Calcium</subject><subject>Cancer</subject><subject>Cell</subject><subject>Cycle</subject><subject>Disease Models, Animal</subject><subject>Endothelin Receptor Antagonists</subject><subject>Humans</subject><subject>Landes</subject><subject>Male</subject><subject>Mice</subject><subject>Molecular Targeted Therapy - methods</subject><subject>Organogenesis</subject><subject>Prostatic Neoplasms - drug therapy</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Proteins</subject><subject>Pyrrolidines - pharmacology</subject><issn>1538-4047</issn><issn>1555-8576</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqFUU1v1DAQtRCIlsKRK8qNU7a2Yzs2BxBd8SVVQkKLxM1ynMmuIbGD7aXqv6_TLSuQKvU0I_vNm3nvIfSS4BUjgpzbLq_USq4IabB6hE4J57yWvBWPl76RNcOsPUHPUvqJMW2pUE_RCcWE41bIU_RjY-IWsvPbKu-gAt-HUkfnqwgW5hxiVfo5hpRNhsoabyFWXfBQTZBNeU0uvakujP1V5XDLMYV9gnfP0ZPBjAle3NUz9P3jh836c3359dOX9fvL2nLS5hoa4ALTHjNigXUDgUENEgvKlRKcNdZSjpUx0LBSZEuLpEGCUIyJtpeqOUNvD7zzvpugt-BzNKOeo5tMvNbBOP3_j3c7vQ1_dIMpkw0tBK_vCGL4vYeU9eSShXE0HooS3TJZLmnpsqo-IG2xI0UYjlsI1ksYuoShlZb6NoyCf_XvaUf0X_cLgBwAZVcPqXMhWQfF4SN0ITQxOzvCkfT8gRmsvoXd-mKzHDL3Q5mQhwnnhxAncxXi2OtsrscQh1gCdUk39yu4ARvOvSo</recordid><startdate>20100415</startdate><enddate>20100415</enddate><creator>Roh, Meejeon</creator><creator>Abdulkadir, Sarki A.</creator><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20100415</creationdate><title>Targeting the endothelin receptor in prostate cancer bone metastasis: Back to the mouse?</title><author>Roh, Meejeon ; Abdulkadir, Sarki A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c517t-e3e5602d041ce4bf1ef9f80625996543cc2509aae3409a872538f8e694467d893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animals</topic><topic>Atrasentan</topic><topic>Binding</topic><topic>Biology</topic><topic>Bioscience</topic><topic>Bone Neoplasms - drug therapy</topic><topic>Bone Neoplasms - secondary</topic><topic>Calcium</topic><topic>Cancer</topic><topic>Cell</topic><topic>Cycle</topic><topic>Disease Models, Animal</topic><topic>Endothelin Receptor Antagonists</topic><topic>Humans</topic><topic>Landes</topic><topic>Male</topic><topic>Mice</topic><topic>Molecular Targeted Therapy - methods</topic><topic>Organogenesis</topic><topic>Prostatic Neoplasms - drug therapy</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Proteins</topic><topic>Pyrrolidines - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roh, Meejeon</creatorcontrib><creatorcontrib>Abdulkadir, Sarki A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer biology &amp; therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roh, Meejeon</au><au>Abdulkadir, Sarki A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Targeting the endothelin receptor in prostate cancer bone metastasis: Back to the mouse?</atitle><jtitle>Cancer biology &amp; therapy</jtitle><addtitle>Cancer Biol Ther</addtitle><date>2010-04-15</date><risdate>2010</risdate><volume>9</volume><issue>8</issue><spage>615</spage><epage>617</epage><pages>615-617</pages><issn>1538-4047</issn><eissn>1555-8576</eissn><abstract>Commentary to: Bone-specific growth inhibition of prostate cancer metastasis by Atrasentan Justin M. Drake, Joshua R. Danke and Michael Henry</abstract><cop>United States</cop><pub>Taylor &amp; Francis</pub><pmid>20150768</pmid><doi>10.4161/cbt.9.8.11309</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1538-4047
ispartof Cancer biology & therapy, 2010-04, Vol.9 (8), p.615-617
issn 1538-4047
1555-8576
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3024832
source PubMed Central; EZB Electronic Journals Library
subjects Animals
Atrasentan
Binding
Biology
Bioscience
Bone Neoplasms - drug therapy
Bone Neoplasms - secondary
Calcium
Cancer
Cell
Cycle
Disease Models, Animal
Endothelin Receptor Antagonists
Humans
Landes
Male
Mice
Molecular Targeted Therapy - methods
Organogenesis
Prostatic Neoplasms - drug therapy
Prostatic Neoplasms - pathology
Proteins
Pyrrolidines - pharmacology
title Targeting the endothelin receptor in prostate cancer bone metastasis: Back to the mouse?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T13%3A51%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Targeting%20the%20endothelin%20receptor%20in%20prostate%20cancer%20bone%20metastasis:%20Back%20to%20the%20mouse?&rft.jtitle=Cancer%20biology%20&%20therapy&rft.au=Roh,%20Meejeon&rft.date=2010-04-15&rft.volume=9&rft.issue=8&rft.spage=615&rft.epage=617&rft.pages=615-617&rft.issn=1538-4047&rft.eissn=1555-8576&rft_id=info:doi/10.4161/cbt.9.8.11309&rft_dat=%3Cproquest_pubme%3E748965729%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c517t-e3e5602d041ce4bf1ef9f80625996543cc2509aae3409a872538f8e694467d893%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=748965729&rft_id=info:pmid/20150768&rfr_iscdi=true